Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hamlet BioPharma AB (publ) | HAMLETB | Apr 26, 2024 | 2.35 | +0.43 |
Hansa Biopharma | HNSA | Apr 26, 2024 | 27.32 | +0.44 |
Hanza AB | HANZA | Apr 26, 2024 | 57.90 | +2.03 |
Harm Reduction Group | NOHARM | Apr 26, 2024 | 0.13 | +13.48 |
Havsfrun Investment | HAVS | Apr 26, 2024 | 13.05 | -0.38 |
Havsfrun Investment B | HAVB | Apr 26, 2024 | 13.05 | -0.38 |
Haypp Group | HAYPP | Apr 26, 2024 | 82.00 | +1.99 |
Headsent | VIMAB | Apr 26, 2024 | 10.25 | -0.97 |
Heba B | HEBAB | Apr 26, 2024 | 32.15 | +2.88 |
Hedera Group | HEGR | Apr 26, 2024 | 5.85 | -5.65 |
Heimstaden Pref | HEIMPREF | Apr 26, 2024 | 9.18 | -1.29 |
Heliospectra | HELIO | Apr 26, 2024 | 0.45 | 0.00 |
Hemnet Group | HEM | Apr 26, 2024 | 283.60 | -1.12 |
Hemply Balance | HMPLY | Apr 26, 2024 | 0.04 | +6.06 |
Hexagon B | HEXAB | Apr 26, 2024 | 120.20 | -1.52 |
Hexagon Purus | HPURO | Apr 26, 2024 | 4.94 | -3.14 |
Hexatronic Group | HTRO | Apr 26, 2024 | 31.84 | +6.13 |
Hexicon | HEXI | Apr 26, 2024 | 0.57 | +1.07 |
Hexpol B | HPOLB | Apr 26, 2024 | 127.30 | -0.55 |
Hifab B | HIFAB | Apr 26, 2024 | 2.78 | +1.46 |
High Coast Distillery B | HIGHCOB | Apr 26, 2024 | 46.00 | +0.88 |
Hilbert | HILBB | Apr 26, 2024 | 4.10 | +1.74 |
HMS Networks | HMS | Apr 26, 2024 | 416.00 | +6.23 |
Hoegh Autoliners ASA | HAUTOO | Apr 26, 2024 | 107.50 | +2.87 |
Hoi Publishing AB | HOIB | Apr 26, 2024 | 0.43 | +10.26 |
Hoist Finance | HOFI | Apr 26, 2024 | 50.50 | +3.27 |
Holmen A | HOLMA | Apr 26, 2024 | 420.00 | -0.71 |
Holmen B | HOLMB | Apr 26, 2024 | 418.60 | -1.37 |
HomeMaid B | HOMEB | Apr 26, 2024 | 15.30 | +4.08 |
Hoodin | HOODIN | Apr 26, 2024 | 0.43 | +39.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.